OVERLAND PHARMA Trademark

Trademark Overview

On Wednesday, March 18, 2020, a trademark application was filed for OVERLAND PHARMA with the United States Patent and Trademark Office. The USPTO has given the OVERLAND PHARMA trademark a serial number of 88839699. The federal status of this trademark filing is REGISTERED as of Tuesday, February 22, 2022. This trademark is owned by OVERLAND PHARMACEUTICALS (US) INC.. The OVERLAND PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical product evaluation; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Scientific research for medical purposes in the area of cancerous diseases; Testing of pharmaceuticals
overland pharma

General Information

Serial Number88839699
Word MarkOVERLAND PHARMA
Filing DateWednesday, March 18, 2020
Status700 - REGISTERED
Status DateTuesday, February 22, 2022
Registration Number6654348
Registration DateTuesday, February 22, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Description of MarkThe mark consists of stylized wordings "OVERLAND PHARMA", and a stylized design of mountain with the flags in a circle on the left of the wordings.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"
Goods and ServicesConducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical product evaluation; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Scientific research for medical purposes in the area of cancerous diseases; Testing of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 23, 2020
Primary Code042
First Use Anywhere DateFriday, May 8, 2020
First Use In Commerce DateFriday, May 8, 2020

Trademark Owner History

Party NameOVERLAND PHARMACEUTICALS (US) INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDover, Kent, DE 19901
Party NameOVERLAND PHARMACEUTICALS (US) INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, Kent, DE 19901
Party NameOVERLAND PHARMACEUTICALS (US) INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, Kent, DE 19901

Trademark Events

Event DateEvent Description
Saturday, March 21, 2020NEW APPLICATION ENTERED
Monday, March 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 24, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 15, 2021SOU EXTENSION 1 FILED
Monday, April 19, 2021ABANDONMENT - NO USE STATEMENT FILED
Monday, April 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 18, 2021PETITION TO REVIVE-GRANTED
Friday, June 18, 2021TEAS PETITION TO REVIVE RECEIVED
Friday, June 18, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, June 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 19, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, July 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 15, 2021SOU EXTENSION 1 GRANTED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2021SOU EXTENSION 2 FILED
Monday, October 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Monday, October 18, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, December 17, 2021PETITION TO REVIVE-GRANTED
Friday, December 17, 2021TEAS PETITION TO REVIVE RECEIVED
Friday, December 17, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 17, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, December 18, 2021NOTICE OF REVIVAL - E-MAILED
Monday, January 3, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022TEAS STATEMENT OF USE RECEIVED
Monday, January 10, 2022USE AMENDMENT FILED
Friday, January 14, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, January 17, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 18, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 22, 2022REGISTERED-PRINCIPAL REGISTER
Monday, December 16, 2024AMENDMENT CORRESPONDENCE ENTERED

Related Keywords

pharma overland research development pharmaceutical pharmaceuticals others trials clinical conducting services medical